Back

A proteomic analysis of 131 biomarkers in relation to infarct size and long-term ejection fraction assessed by CMR in patients with ST-segment elevation myocardial infarction

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 6 - Latest on STEMI Infarction acute phase STEMI ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Moman Aladdin Mohammad

Skane University Hospital, Lund (Sweden)

70 More presentations in this session

Presentation thumbnail
Acquired thrombocytopenia after transcatheter aortic valve implantation (TAVI): association with clinical outcome
Doctor C. Guerreiro (Vila Nova de Gaia, PT)
Abstract
Presentation thumbnail
Ventricular conduction blocks: prevalence, temporal evolution, and impact on survival in cardiogenic shock
Doctor H. Tolppanen (Helsinki, FI)
Abstract Slides
Presentation thumbnail
Pre-hospital and in-hospital mortality from myocardial infarction in Berlin
Professor M. Stockburger (Nauen, DE)
Abstract Slides
Presentation thumbnail
Development of antithrombotic therapy and bleeding complications in patients with ACS over time: Data from a local myocardial infarction registry
Doctor J. Roehnisch (Berlin, DE)
Abstract Slides
Presentation thumbnail
8-hydroxy-2-deoxyguanosine predicts microvascular obstruction after primary percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction.
Mr Y. Minamimoto (Yokohama, JP)
Abstract

Access the full session

Session thumbnail
Poster session 6 - Latest on STEMI

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources